Intravenous or intraperitoneal administration of a tripeptide co

Details Intravenous or intraperitoneal administration of a tripeptide co Intravenous or intraperitoneal administration of a tripeptide co

1984-07-02

1987-05-19

Hazel, Blondel

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

530331, A61K 3502

Patent

active

046668870

ABSTRACT:
A pharmaceutical composition for use in the treatment of malignant tumor cells in laboratory animals is disclosed. The pharmaceutical composition uses a pharmaceutically acceptable excipient with a tripeptide compound as the active ingredient. The tripeptide compound is formed from dichlorodiethylaminophenylalanine, parafluorophenylalanine, and methione.

REFERENCES:
patent: 4087520 (1978-05-01), Bran et al.
patent: 4127534 (1978-11-01), Coy et al.
patent: 4153688 (1979-05-01), Dimicoli et al.

Affiliated with

Also associated with

Rating

Intravenous or intraperitoneal administration of a tripeptide co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intravenous or intraperitoneal administration of a tripeptide co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous or intraperitoneal administration of a tripeptide co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1564931